-
European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
Today's GeNeuro patent milestone adds a potentially significant ALS opportunity to an already expanding NRx platform, while HOPE Therapeutics advances robotic TMS deployment and the company's preservative-free ketamine program moves closer to commercializ. Read more
-
FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
NRx's HOPE Therapeutics is preparing to deploy Zeta Surgical's newly FDA-cleared robotic TMS technology in Florida, adding another major piece to a rapidly expanding neuropsychiatric platform while the company advances toward potential 2026 commercializat. Read more
-
Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S. commercial footprint and a new IRE technology partnership, $BDMD is building a broader minimally invasive medical technology plat. Read more
-
Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
With its Nevada refinery preparing to return to production, a potentially transformative $50 million oil-development initiative underway and innovative resource-recovery technology in its portfolio, Sky Quarry $SKYQ is positioning itself for an exciting p. Read more
-
Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
Strategic Appointments Bring Decades of U.S. Military and Government Experience to (NAS DAQ: ASTI) $ASTI as NASA-Related Testing, MEO/GEO Qualification, Spacecraft Deployments, Drones, HAPS and Autonomous Systems Expand the Company's Commercial Opportunit. Read more
-
54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
~$30 Million Revenue Run Rate, 800+ New Public-Safety Customers, New Patents and $500,000 Share Repurchase Program Highlight a Dramatic 2026 Transformation. Read more
-
StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
StockResearch AI Initiates Coverage on Apple With New Report Examining Valuation, AI Strategy and Future Growth. Read more
-
5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
Cycurion, Inc. (NAS DAQ: CYCU) $CYCU Recently Announced a $500,000 Share Repurchase Plan Plus US Patent Protection Extended on Vital Technology for Wide Ranging Security Platforms.. Read more
-
Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
With NASA testing demonstrating potential radiation self-annealing in ASTI's CIGS technology, the Company is now expanding its validation program beyond Low Earth Orbit as demand grows for lightweight, resilient solar solutions for space-based power, orbi. Read more
-
FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
Q2 update reinforces the central NRXP investment thesis: preservative-free ketamine is moving toward commercialization while NRX-101, DARPA funding, HOPE Therapeutics and a stronger balance sheet create multiple potential catalysts.. Read more
-
Merger Advancement For Embodied AI Co in Robotic Systems Serving High Value Hospitality, Gaming & Real Estate Sectors: MBody AI Corp. (NAS DAQ: MBAI)
MBody AI Corp / Check-Cap Ltd. (NAS DAQ: MBAI) $MBAI Operates in the $16 Billion 2026 North American Service Robotics Market Projected to Reach $29 Billion by 2031. Read more
-
FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.. Read more
-
Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution. Read more
-
Expanding Beyond Space as New Drone Market Opportunities Accelerate Growth: Ascent Solar Technologies (N A S D A Q: ASTI)
Latest Commercial Wins Highlight Expanding Demand for Ascent's Lightweight Thin-Film Solar Technology Across Space, Defense, High-Altitude Platforms, Drones and Autonomous Marine Systems While Reinforcing the Company's Primary Focus on the Fast-Growing Sp. Read more
-
$40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
Leading Innovators in the Emerging AUV/Drone Sector Include ZenaTech (N A S D A Q: ZENA) $ZENA, Draganfly (N A S D A Q: DPRO) $DRPO, Quantum Cyber N.V. (N A S D A Q: QUCY) $QUCY, Unusual Machines, (N YS E American: UMAC) $UMAC, Safe Pro Group Inc. (N A S . Read more
-
$620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
Record financial performance, expanding European government partnerships, and an integrated technology platform position Circle8 Group $CIRC for its next phase of long-term growth.. Read more
-
AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
With 640% first-quarter revenue growth, a rapidly expanding Drone-as-a-Service platform, strategic acquisitions across North America, AI and quantum computing initiatives, and growing defense opportunities, ZenaTech $ZENA is executing an ambitious strateg. Read more
-
DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
Potential DARPA Award, FDA-Authorized Phase 2/3 Trial, Breakthrough Therapy NRX-101, and Robotic-Enabled TMS Platform Highlight Expanding Opportunities for NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP). Read more
-
From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
As Formula One becomes one of the world's fastest-growing sports, $CIRC is leveraging its partnership with the Aston Martin Aramco Formula One® Team to showcase the same elite talent strategy that is driving more than $1.2 billion in annualized revenue an. Read more
-
Is the Market Missing One of the Most Undervalued Cybersecurity Companies on the Stock Market? Cycurion, Inc. (N A S D A Q: CYCU):
With a Growing AI-Driven Cybersecurity Platform, $112 Million Contract Backlog, and Strategic Acquisitions, Cycurion $CYCU May Be Positioned for Significant Long-Term Growth. Read more
-
Billion-Dollar Scale Global Technology Powerhouse Being Built with Expanding Government Contracts: Circle8 Group (N A S D A Q: CIRC)
Following a transformational acquisition, record financial growth, and more than $600 million in recent public-sector contract awards, Circle8 Group $CIRC is positioning itself as a leading global technology and workforce solutions platform.. Read more
Your online source of trusted news